A Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General Practice
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity of Copenhagen
About this trial
It is widely acknowledged that prostate specific antigen (PSA) testing can lead to false-positives, overdiagnosis and overtreatment of prostate cancer. The current national clinical guidelines only recommend the test to a small group of patients and does not recommend neither systematic nor opportunistic screening for prostate cancer with the test.
The aim of this cluster randomized trial is to evaluate the effectiveness of a complex intervention aimed at improving the use of evidence based practice when using prostate specific antigen tests in general practice.
The complex intervention in this study is a so called cluster package which is meeting material to a quality cluster meeting as almost every general practitioner is a member of a quality cluster. Therefore, the investigators have developed a cluster package aimed at promoting an evidence-based use of the prostate specific antigen test to general practitioners.
Eligibility criteria
Qualifiers
Quality clusters with a cluster coordinator
Quality clusters willing to participate in a cluster meeting with PSA as a theme in 2025.
Disqualifiers
Quality clusters who already planned their cluster meetings in 2025.
Quality clusters unwilling to await allocation before planning their cluster meetings in 2025.
Quality clusters participating in the pilot study
Trial design
Treatments tested in this trial
- Podcast
- Cluster meeting
- Hand-out material 1
- Hand-out material 2
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Copenhagen
Lead sponsor
Kvalitet i Almen Praksis (KiAP)
Collaborator
Source ClinicalTrials.gov